| abstract |
The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine composition for treating novel coronavirus pneumonia (COVID-19) and application thereof. The traditional Chinese medicine composition is prepared from the following raw material medicines in parts by weight: 15-25 parts of astragalus membranaceus, 12-18 parts of radix pseudostellariae, 15-25 parts of poria cocos, 4-8 parts of liquorice, 25-35 parts of fried semen coicis, 8-12 parts of fructus amomi, 10-15 parts of rhizoma corydalis, 8-12 parts of radix curcumae, 25-35 parts of radix paeoniae alba, 6-10 parts of angelica sinensis, 10-15 parts of radix paeoniae rubra, 25-35 parts of lalang grass rhizome, 10-15 parts of rhizoma atractylodis macrocephalae, 25-35 parts of herba pyrrosiae, 25-35 parts of herba artemisiae scopariae, 25-35 parts of endothelium corneum gigeriae galli and 10-18 parts of radix puerariae. The invention has obvious curative effect on common COVID-19 type and severe type liver and gall stagnated heat and patients in convalescent period without clearing residual evil. |